XRP Price Prediction: Korea and Binance Power the Rally, But Can XRP Keep Going?
XRP trades near $1.42 after a 43.7% rally fueled by Korean turnover and Binance positioning. Can it clear $1.52 resistance or is a...
Solana Treasury Firm Invites Investors to Look 'Beyond the Price of SOL'
Nasdaq-listed SOL treasury company DeFi Development Corp launched a free network dashboard on Wednesday. Its pitch: judge Solana o...
Chainalysis estimates $457B in taxable crypto activity, says CARF misses most
The blockchain analytics firm said just 14% of the onchain activity it identified is covered by the OECD’s international crypto ta...
'The Government Doesn't Own Our Data': Prosecuted GrapheneOS User
Samuel Tunick, facing five years over a wiped phone, said he was secretly placed on a watch list as a suspected terrorist.
Market Movers Today: Nvidia (NVDA) Earnings, Inflation Jump, and Meta (META) Leg...
Nvidia earnings awaited as inflation hits 3.7%, Intuit misses forecasts, Meta settles lawsuits, and oil falls below $90. Today's k...
Crypto CEO Faces US Extradition Over Alleged $20 Million Token Scheme
Manpreet Kohli, accused of making $20 million from an alleged scheme to manipulate the Saitama token, is a step closer to facing t...
Alibaba (BABA) Stock: Qwen Slashes AI Training Costs by 89% with New Qwen3.8-Fla...
Alibaba (BABA) launches Qwen3.8-Flash AI model with 89% cost reduction and enhanced performance. Qwen3.8-Flash-Next previews upcom...
Meta (META) Stock: How Zuckerberg’s AI Workforce Strategy Crashed and Burned
Meta (META) stock faces scrutiny after leaked Project OT documents show abandoned plans for 60% team cuts due to AI failures and e...
BofA: SpaceX Wireless Expansion Would Lift T-Mobile (TMUS) and Tower Stocks, Not...
Bank of America says SpaceX's wireless ambitions face major obstacles and would likely benefit T-Mobile and tower companies rather...
Revolution Medicines (RVMD) Stock Climbs After Early FDA Green Light for Pancrea...
Revolution Medicines (RVMD) stock gained after the FDA granted early approval to Rasonque for pancreatic cancer, with trial data s...